Tag: Cancer Immunotherapy
Global Cancer Immunotherapy market to reach US$ 412.8 billion by 2034:...
With a projected CAGR of 10%, the cancer immunotherapy market is poised for significant growth, fueled by advancements in treatment technologies
Narayana Health initiates phase II clinical trial of CAR-T
The modified cells called CAR-T cells circulate in patients' body and selectively kill the cancer cells. Unlike chemotherapy, this treatment is highly selective immunotherapy
Immunotherapy to tackle cancer, India tests first dendritic cell vaccine
Cancer antigen SPAG9 discovered at National Institute of Immunology after being tested successfully in the first phase of clinical trials, is now undergoing second phase of trials involving longer and detailed study.......
Emerging technologies driving disruption in health and wellness
Top technologies improve outcomes in healthcare through innovation, impelling growth opportunities ...